A 32-year-old woman from Mumbai presents with a 5-year history of amenorrhoea and infertility. She reports progressive weight gain (18 kg over 5 years), fatigue, and cold intolerance. On examination, BMI is 31 kg/m², skin is dry, and there is mild facial puffiness. Pelvic ultrasound shows bilateral polycystic ovaries (>12 follicles per ovary). Serum testosterone is 0.6 ng/mL (normal <0.7), LH:FSH ratio is 1.8:1, TSH is 8.2 mIU/L (normal 0.4–4.0), and free T4 is 0.8 ng/dL (normal 0.8–1.8). Fasting insulin is 18 mIU/L (normal <12). What is the most important initial intervention to optimize her fertility potential?

Explanation

## Clinical Diagnosis: PCOD + Primary Hypothyroidism This patient has **two concurrent disorders** affecting fertility: ### 1. PCOD (Confirmed) - Amenorrhoea + infertility - Polycystic ovarian morphology on ultrasound - Elevated LH:FSH ratio (1.8:1, though mildly elevated) - Hyperinsulinaemia (fasting insulin 18 mIU/L) ### 2. **Primary Hypothyroidism (Critical Finding)** - **TSH 8.2 mIU/L** (elevated; normal <4.0) - **Free T4 0.8 ng/dL** (low-normal; normal 0.8–1.8) - Clinical features: fatigue, cold intolerance, dry skin, weight gain, facial puffiness ## Why Levothyroxine is the MOST Important First Intervention **Key Point:** Untreated hypothyroidism is a **reversible cause of amenorrhoea and infertility** that MUST be corrected before pursuing ovulation induction. ### Mechanism of Hypothyroidism-Induced Amenorrhoea 1. **↑ TRH** (due to low T4) → **↑ Prolactin** (TRH stimulates prolactin release) 2. **Hyperprolactinaemia** → **suppresses GnRH** → **↓ LH/FSH** → **anovulation and amenorrhoea** 3. **Impaired GnRH pulsatility** and **↓ ovarian sensitivity to gonadotropins** 4. **Impaired luteal phase** (↓ progesterone synthesis) **High-Yield:** Hypothyroidism causes **secondary amenorrhoea** even in the absence of elevated prolactin levels. Correcting thyroid function is essential for restoring ovulation. ### Treatment Target **Mnemonic:** **TSH Goal in Fertility = 0.5–2.5 mIU/L** (tighter control than general population) - Start **levothyroxine 25–50 mcg daily**, titrate by 25 mcg every 6–8 weeks - Recheck TSH after 6–8 weeks - Target TSH 0.5–2.5 mIU/L (lower end for PCOD + infertility) - Allow 6–12 weeks after achieving euthyroid state before assessing ovulation **Clinical Pearl:** Many women with PCOD have concurrent autoimmune thyroiditis (Hashimoto's). Screening for TPO antibodies is recommended. ## Why Other Options Are Premature | Option | Why Not First-Line | |--------|-------------------| | **Clomiphene citrate** | Cannot use until euthyroid; clomiphene may worsen hypothyroid symptoms; will not work if TSH is elevated | | **Metformin monotherapy** | Addresses insulin resistance but does NOT correct hypothyroidism-induced amenorrhoea; metformin + levothyroxine would be appropriate AFTER thyroid correction | | **Letrozole** | Same as clomiphene — premature without thyroid correction; aromatase inhibitors are less effective in untreated hypothyroidism | **Warning:** Attempting ovulation induction (clomiphene, letrozole) in a hypothyroid woman is futile and delays diagnosis. Thyroid function MUST be optimized first. ## Sequential Management Plan ```mermaid flowchart TD A[Amenorrhoea + Infertility]:::outcome --> B{Check TSH & Free T4}:::decision B -->|TSH elevated| C[Start Levothyroxine]:::action C --> D[Titrate to TSH 0.5-2.5 mIU/L]:::action D --> E[Wait 6-12 weeks for euthyroid state]:::action E --> F{Menses resumed?}:::decision F -->|Yes| G[Reassess PCOD; add metformin if needed]:::action F -->|No| H[Consider ovulation induction: clomiphene/letrozole]:::action B -->|TSH normal| I[Proceed with PCOD management]:::action ``` [cite:Harrison 21e Ch 405, Endocrine Society Clinical Practice Guidelines on Hypothyroidism 2012]